ABT stock: buy or sell?

ABT stock price: $87.45 -1.14% At close on February 21st, 2020

Updated on:
February 21st, 2020

4

Abbott Laboratories depreciated an unpleasant -1.14% and closed at $87.45.

Should I buy ABT stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Abbott Laboratories stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean ABT will fall in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Abbott Laboratories stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't find any rating for ABT stock for the last 30 days.

ABT stock analysis

Daily outlook

Abbott Laboratories ended on February 21st at $87.45 and depreciated an unpleasant -1.14%.

Abbott Laboratories shares depreciated -1.14% to $87.45 on Feb 21st. On October ABT price bounced up over the SMA of 200 days demonstrating to be a significant support for this stock. On December, SMA50d and SMA100d crossed up triggering a rise of 1.03%. On Jan 22nd, ABT hit a new all time high, pushing higher than on January 21st tops. Check different trading setups that use ATHs as triggers.

ABT stock chart (daily)

Weekly outlook

Abbott Laboratories shares dropped -2.46% this week, ending at $87.45.

ABT shows a long term strength with several rising tops and rising bottoms. It left a new bottom at $86.75 early February. Previous top ($92.45) will play as a resistance in possible new gains. Not so far away is the last price record Abbott Laboratories marked late January. By mid December 2019, SMA10w and SMA20w crossed up triggering a rise of 1.71%. Since late November 2019 when ABT stock price broke up the SMA20w line, it gained $4.06 (4.87%).

ABT stock chart (weekly)

ABT stock price history

ABT stock went public on March 17th, 1980 with a price of $0.001. Since then, ABT stock grew a inf%, with a yearly average of inf%. If you had invested $1,000 in ABT stock in 1980, it would worth $inf today.

1: Adjusted price after possible price splits or reverse-splits.

ABT stock historical price chart

ABT stock reached all-time highs on Jan 22nd with a price of $92.45.

ABT stock price target

How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. You should not follow the analysts' ABT stock price predictions in the hope that they will be met as they may be wrong and not met. For the last month we have not found any price forecast for Abbott Laboratories stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

After publishing its last earnings report on April, Abbott Laboratories . Unfortunately, reported EPS is not yet available in our database.
ABT earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a0.17n/a
2017-Q32017-10-180.650.661.5%
2017-Q42018-01-240.730.741.4%
2018-Q12018-04-180.580.591.7%
2018-Q22018-07-180.710.732.8%
2018-Q32018-10-170.740.751.4%
2018-Q42019-01-230.810.810.0%
2019-Q12019-04-160.61n/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

Compared to 2017, last anual turnover report draw a cool increase of 11.64% to $30,578.00 million dollars. When comparing 2018 vs 2017, on the other hand, profit margin (that is, the net income divided by revenues) escalated a 6.00% to 7.74%.

Abbott Laboratories fiscal year ends in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Abbott Laboratories TTM sales up to March 2019 were $30,723.00 and earnings $2,622.00 million USD. If we compare this TTM figures with the last reported annuality, we can esteem Abbott Laboratories business evolution since December 2018: Annual turnover up to March, compared to lastest yearly report, remained steady a tight 0.47%. Similarly, profit margin (net income/revenues) stayed constant at 7.74%.

ABT annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$19,660 M-$1,970 M10.0%-
2014$20,247 M2.99%$2,284 M11.3%15.94%
2015$20,405 M0.78%$4,423 M21.7%93.65%
2016$20,853 M2.20%$1,400 M6.7%-68.35%
2017$27,390 M31.35%$477 M1.7%-65.93%
2018$30,578 M11.64%$2,368 M7.7%396.44%
TTM $30,723 M0.47%$2,622 M8.5%10.73%

Quarterly financial results

Abbott Laboratories posted $7,535.00 million in sales for 2019-Q1, a -2.96% decline compared to previous quarter. Reported quarter income marked $672.00 M with a profit margin of 8.92%. Profit margin remained steady a 0.50% compared to previous quarter when profit margin was 8.42%. When comparing sales to same quarter last year, Abbott Laboratories sales marked a slightly good growth and appreciated a 1.96%.
ABT quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$6,640 M-$269 M4.1%-
2017-Q3$6,830 M2.86%$558 M8.2%107.43%
2017-Q4$7,589 M11.11%$-828 M-10.9%-248.39%
2018-Q1$7,390 M-2.62%$418 M5.7%-150.48%
2018-Q2$7,767 M5.10%$733 M9.4%75.36%
2018-Q3$7,656 M-1.43%$563 M7.4%-23.19%
2018-Q4$7,765 M1.42%$654 M8.4%16.16%
2019-Q1$7,535 M-2.96%$672 M8.9%2.75%

Abbott Laboratories ownership

When you are planning to buy shares of a company, it's always worth to check its ownership structure.

Abbott Laboratories shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.70% of all shares.

In case of Abbott Laboratories stock, 76.53% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ABT stock account 0.00%, no big difference from last month.

For a better context understanding, the next table shows ownership data compared to other related stocks:

ABT
Market cap$154.8 B
Total shares1,770.0 M
Float shares1,760.0 M
  - Institutional holdings (%)76.5%
  - Insider holdings (%)0.7%
Shares in short selling0.0%

ABT summary

Friday, February 21st, 2020
Open$88.04
Close$87.45
Day range$87.16 - $88.25
Previous close$88.46
Session gain-1.14%
Average true range$1.37
50d mov avg$87.55
100d mov avg$85.02
200d mov avg$83.55
Daily pattern
Weekly pattern lb03a

Abbott Laboratories performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. For Abbott Laboratories, the benchmark is made against .
Stock3m6m12m
ABT4.87%7.62%16.72%

Abbott Laboratories competitors

Unfortunately, we could not find any public company that could be defined as Abbott Laboratories competitor. This doesn't mean Abbott Laboratories does not have any competitor in the market, it's just we could not detected it.

    Latest ABT stock news